Nur Nicholson - Net Worth and Insider Trading
Nur Nicholson Net Worth
The estimated net worth of Nur Nicholson is at least $2 Million dollars as of 2024-11-13. Nur Nicholson is the Chief Technical Officer of Apellis Pharmaceuticals Inc and owns about 56,287 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $2 Million. Details can be seen in Nur Nicholson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nur Nicholson has not made any transactions after 2024-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nur Nicholson
Nur Nicholson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nur Nicholson owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .
Click here to see the complete history of Nur Nicholson’s form 4 insider trades.
Insider Ownership Summary of Nur Nicholson
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2024-03-13 | Chief Technical Officer |
Nur Nicholson Latest Holdings Summary
Nur Nicholson currently owns a total of 1 stock. Nur Nicholson owns 56,287 shares of Apellis Pharmaceuticals Inc (APLS) as of March 13, 2024, with a value of $2 Million.
Latest Holdings of Nur Nicholson
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2024-03-13 | 56,287 | 29.26 | 1,646,958 |
Holding Weightings of Nur Nicholson
Nur Nicholson Form 4 Trading Tracker
According to the SEC Form 4 filings, Nur Nicholson has made a total of 5 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 11,220 shares on March 13, 2024, which brought Nur Nicholson around $645,823.
Insider Trading History of Nur Nicholson
- 1
Nur Nicholson Trading Performance
Nur Nicholson Ownership Network
Ownership Network List of Nur Nicholson
Ownership Network Relation of Nur Nicholson
Nur Nicholson Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Nur Nicholson is the Chief Technical Officer of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Nur Nicholson made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 296,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .
In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,263,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,263,451 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Nur Nicholson Mailing Address
Above is the net worth, insider trading, and ownership report for Nur Nicholson. You might contact Nur Nicholson via mailing address: Apellis Pharmaceuticals, Inc., 100 5th Avenue, 3rd Floor, Waltham Ma 02451.